These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32460975)

  • 1. Establishing specific response criteria for MDS/MPN - Getting closer to reality?
    Villaume MT; Savona MR
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101170. PubMed ID: 32460975
    [No Abstract]   [Full Text] [Related]  

  • 2. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults.
    Savona MR; Malcovati L; Komrokji R; Tiu RV; Mughal TI; Orazi A; Kiladjian JJ; Padron E; Solary E; Tibes R; Itzykson R; Cazzola M; Mesa R; Maciejewski J; Fenaux P; Garcia-Manero G; Gerds A; Sanz G; Niemeyer CM; Cervantes F; Germing U; Cross NC; List AF;
    Blood; 2015 Mar; 125(12):1857-65. PubMed ID: 25624319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speaking a common language in MDS/MPNs.
    Steensma DP
    Blood; 2015 Mar; 125(12):1849-51. PubMed ID: 25792730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.
    Lasky J; Sakamoto KM
    MedGenMed; 2005 Mar; 7(1):21. PubMed ID: 16369326
    [No Abstract]   [Full Text] [Related]  

  • 5. The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms.
    Ragon BK; Savona MR
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S37-S42. PubMed ID: 28760301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic/myeloproliferative neoplasms.
    Hyjek E; Vardiman JW
    Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.
    Loghavi S; Wang SA
    Surg Pathol Clin; 2019 Sep; 12(3):651-669. PubMed ID: 31352979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Advances in diagnosis of hematological disorders.
    Choudhry VP
    Indian J Pediatr; 2013 Sep; 80(9):754-5. PubMed ID: 23943572
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.
    Sharma P; Shinde SS; Damlaj M; Hefazi Rorghabeh M; Hashmi SK; Litzow MR; Hogan WJ; Gangat N; Elliott MA; Al-Kali A; Tefferi A; Patnaik MM
    Leuk Lymphoma; 2017 Apr; 58(4):872-881. PubMed ID: 27687869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant?
    Sangiorgio VFI; Orazi A; Arber DA
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101139. PubMed ID: 32460987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study.
    Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R
    Leuk Lymphoma; 2015 Apr; 56(4):896-902. PubMed ID: 25058372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic Syndrome Updated.
    Hasserjian RP
    Pathobiology; 2019; 86(1):7-13. PubMed ID: 30041243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: clinical correlates and prognostic studies.
    Pardanani A; Drake MT; Finke C; Lasho TL; Rozell SA; Jimma T; Tefferi A
    Am J Hematol; 2011 Dec; 86(12):1013-6. PubMed ID: 22086864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myelodysplastic syndromes and myeloproliferative disorders.
    Williams JL
    Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
    Anastasi J
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic/myeloproliferative disorders.
    Malcovati L; Cazzola M
    Haematologica; 2008 Jan; 93(1):4-6. PubMed ID: 18166777
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a "catch-all" term?
    Shallis RM; Zeidan AM
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101132. PubMed ID: 32460977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update from the latest WHO classification of MPNs: a user's manual.
    Passamonti F; Maffioli M
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):534-542. PubMed ID: 27913526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.